Monday, 1 Sept
42
ECP 2014 ·
London
Scientific Programme
a
Monday
SY-12
Symposium
08:30 – 12:00
ICC Capital Suite 17
IT in Pathology
Digital pathology in routine diagnosis:
Application, barriers, consultation, and
standardization
Part 1
Chairs:
Marcial Garcia Rojo,
Spain
Gian Kayser,
Germany
001
08:30 – 08:45
The virtual international pathology institute:
Virtual slides, measurements, consultation
Stephan Borkenfeld,
Germany
002
08:45 – 09:00
The progress of digital pathology in the Middle
East
Essam Ayad,
Egypt
003
09:00 – 09:30
How to better integrate virtual slides into the
daily workflow
Manfred Dietel,
Germany
Part 2
Chairs:
Klaus Kayser,
Germany
David Ameisen,
France
004
10:30 – 10:45
Entropy: A useful tool for diagnosis assis-
tance in virtual microscopy?
Konradin Metze,
Brazil
005
10:45 – 10:55
Virtual microscopy in routine biopsy diagnosis
Marius Nap,
The Netherlands
006
10:55 – 11:10
Standards on digital pathology imaging
Marcial Garcia Rojo,
Spain
007
11:10 – 11:20
Automatic analysis of tissue microarrays
using virtual microscopy and Definiens
TMA software
Helmut Popper,
Austria
008
11:20 – 11:35
Digital immunohistochemistry to retrieve
novel information on biomarker expression
Arvydas Laurinavicius,
Lithuania
009
11:35 – 12:00
Predictive diagnosis and automated mea-
surements in virtual slides
Gian Kayser,
Germany
OFP-07
Oral Free Paper Session
08:30 – 12:00
ICC Capital Suite 1
Breast Pathology
Chairs:
Anna Sapino,
Italy
Zsuzsanna Varga,
Switzerland
James Going,
United Kingdom
001
08:30 – 08:40
Links between pathology and transcrip-
tomes in breast cancer: Exploring the
METABRIC cohort
Abhik Mukherjee,
United Kingdom
E. Provenzano, S.-F. Chin, R. Russell,
O. Rueda, B. Liu, G. Turashvili,
B. Mahler-Araujo, I. Ellis, S. Aparicio,
C. Caldas
002
08:40 – 08:50
Biological and clinical significance of PARP1
protein expression in breast cancer
Andrew Green,
United Kingdom
D. Caracappa, A. Benhasouna, A. Alshareeda,
C. Nolan, D. Macmillan, S. Madhusudan,
I. Ellis, E. Rakha
003
08:50 – 09:00
Audit of consistency of DCIS grading in
breast core biopsies and excision specimens
Mark Ong,
United Kingdom
S. Pinder
004
09:00 – 09:10
Assessing the prognostic significance of ma-
trix metalloproteinases 14 & 15 in primary
breast cancer
Thomas Chadwick,
United Kingdom
R. Russell, O. Rueda, S.-F. Chin, B. Liu,
M. Craze, E. Provenzano, C. Caldas, I. Ellis,
A. Mukherjee
006
09:10 – 09:20
Human epidermal growth factor receptor 2
testing in core biopsies of the breast: Does
size matter? The experience of a Tertiary
Care Hospital
André Coelho,
Portugal
F. Moreno, J. Ramón Vizcaíno
007
10:30 – 10:40
DNA repair markers are differentially ex-
pressed in BRCA-mutated breast cancers
Andrew Green,
United Kingdom
D. Caracappa, C. Nolan, D. Macmillan,
I. Ellis, E. Rakha
